▼ SELL
10b5-1 Plan
$ Value
$142K
Shares
20,272
Price
$7
Filed
Oct 17
Insider
Name
Kraus Carl N
Title
Chief Medical Officer
CIK
0001946475
Roles
Officer
Transaction Details
Transaction Date
2025-10-15
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
282,475
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. | The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
Filing Info
Other Insiders at AQST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
TOTH A ERNEST JR
Chief Financial Officer
|
— | $243K | 2026-03-10 |
|
TOTH A ERNEST JR
SVP, Chief Financial Officer
|
— | — | 2025-03-07 |
|
Boyd Peter E.
Chief People Officer
|
— | $124K | 2026-03-10 |
|
Barber Daniel
President and CEO
|
— | $754K | 2026-03-10 |
|
BRAENDER LORI J
Chief Legal Officer
|
— | $167K | 2026-03-10 |
|
BRAENDER LORI J
Corporate Secretary
|
— | — | 2025-03-07 |
|
Jung Cassie
Chief Operating Officer
|
— | $191K | 2026-03-10 |
|
Korczynski Sherry
Chief Commercial Officer
|
— | $66K | 2026-03-10 |
|
Cioffi Melina
SVP, Regulatory Affairs
|
— | $106K | 2026-03-10 |
|
Davis Matthew W.
Chief Development Officer
|
— | — | 2026-03-09 |
|
Greenhawt Matthew J.
Chief Medical Officer
|
— | — | 2026-03-09 |